Tomas Albrektsson1, Ann Wennerberg. 1. Department of Biomaterials/Handicap Research, Institute for Surgical Sciences, Göteborg University, Sweden. tomas.albrektsson@biomaterials.gu.se
Abstract
PURPOSE: This article reviews clinical knowledge of selected oral implant surfaces. MATERIALS AND METHODS: The surfaces most commonly used in clinical practice, marketed by the five largest oral implant companies, are identified; their clinical documentation was scrutinized following a strict protocol. Experimental knowledge of the surfaces is briefly summarized. Retrospective, prospective, and comparative clinical studies were analyzed separately, as were studies of implants in conjunction with bone grafts. RESULTS: TiUnite anodized surfaces are clinically documented in 1- to 2-year follow-up studies at best, with failures at about 3%. Sandblasted and acid-etched SLA surfaces are documented with good clinical results for up to 3 years. Osseotite dual acid-etched implants are documented with good clinical results for up to 5 years. Frialit-2 sandblasted and etched implants are positively documented for about 3 years in one study only. The Tioblast implant is the only design documented for survival over 10 years of follow-up and success over 7 years of follow-up. CONCLUSION: Generally, oral implants are introduced clinically without adequate clinical documentation. Implant companies initiate clinical documentation after product launch. The standards of clinical reporting have improved over the years. Proper long-term reports have been published for only one surface, Tioblast.
PURPOSE: This article reviews clinical knowledge of selected oral implant surfaces. MATERIALS AND METHODS: The surfaces most commonly used in clinical practice, marketed by the five largest oral implant companies, are identified; their clinical documentation was scrutinized following a strict protocol. Experimental knowledge of the surfaces is briefly summarized. Retrospective, prospective, and comparative clinical studies were analyzed separately, as were studies of implants in conjunction with bone grafts. RESULTS: TiUnite anodized surfaces are clinically documented in 1- to 2-year follow-up studies at best, with failures at about 3%. Sandblasted and acid-etched SLA surfaces are documented with good clinical results for up to 3 years. Osseotite dual acid-etched implants are documented with good clinical results for up to 5 years. Frialit-2 sandblasted and etched implants are positively documented for about 3 years in one study only. The Tioblast implant is the only design documented for survival over 10 years of follow-up and success over 7 years of follow-up. CONCLUSION: Generally, oral implants are introduced clinically without adequate clinical documentation. Implant companies initiate clinical documentation after product launch. The standards of clinical reporting have improved over the years. Proper long-term reports have been published for only one surface, Tioblast.
Authors: Rafael Manfro; Marcelo Carlos Bortoluzzi; Vinícius Fabris; Carlos Nelson Elias; Vera Cavalcanti de Araújo Journal: J Maxillofac Oral Surg Date: 2013-09-13
Authors: Fabio Variola; John B Brunski; Giovanna Orsini; Paulo Tambasco de Oliveira; Rima Wazen; Antonio Nanci Journal: Nanoscale Date: 2010-10-26 Impact factor: 7.790
Authors: Zvi Schwartz; Perry Raz; Ge Zhao; Yael Barak; Michael Tauber; Hai Yao; Barbara D Boyan Journal: J Bone Joint Surg Am Date: 2008-11 Impact factor: 5.284
Authors: J V Ríos-Santos; A M Menjívar-Galán; M Herrero-Climent; B Ríos-Carrasco; A Fernández-Palacín; R A Perez; F J Gil Journal: J Mater Sci Mater Med Date: 2018-06-26 Impact factor: 3.896
Authors: Mia Rakic; Pablo Galindo-Moreno; Alberto Monje; Sandro Radovanovic; Hom-Lay Wang; David Cochran; Anton Sculean; Luigi Canullo Journal: Clin Oral Investig Date: 2017-12-07 Impact factor: 3.573